Rare Disease Show : Episode 6 Understanding Acanthocytosis Chorea Ft. Dr Syamlal S - Video
|
Overview
Medical Dialogues presents a rare disease series, delving into the realm of uncommon medical conditions. Rare diseases are medical conditions that affect only a small percentage of the population. Throughout this series, we'll discuss these rare diseases in various episodes, with medical experts providing clear explanations and insights.
Rare Disease Show Episode 6-- In today's show we will cover Acanthocytosis Chorea.
Chorea-acanthocytosis is a rare autosomal recessive disease caused by a mutation of the VPS13A gene. The age of onset is typically between 25 and 45 years and manifests with buccolingual dyskinesias, tongue protrusions (“feeding dystonia”), mutilations of tongue and lips, generalized chorea, and peripheral neuropathy. Blood smears may show acanthocytes and elevation of CK levels is seen in most cases. Western blot is more specific and shows reduced chorein expression. In this episode, Dr. Syamlal S, Senior Consultant- Neurology shares his insights by addressing questions asked by the Medical Dialogues team.
1. Firstly, can you provide us an overview of Acanthocytosis Chorea, its primary characteristics and most importantly why is it known as a rare disease?
2. What are the causes of Acanthocytosis Chorea, and how is it genetically inherited?
3. What are the early signs and symptoms of Acanthocytosis Chorea that patients and families should be aware of?
4. How is Acanthocytosis Chorea diagnosed, and what tests are typically used to confirm the diagnosis?
5. What role do acanthocytes (abnormal red blood cells) play in the development of chorea and other neurological symptoms?
6. What treatment options are available for managing the symptoms of Acanthocytosis Chorea and how effective are the current treatments in slowing the progression of the disease and improving the quality of life for patients?
7. Does physical therapy, diet or lifestyle modifications play an important role in the management of Acanthocytosis Chorea?
8. Lastly, if you can highlight any recent advancements in research or potential new treatments for Acanthocytosis Chorea?
Speakers
Dr. Nandita Mohan
BDS, MDS( Pedodontics and Preventive Dentistry)
Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Syamlal S (MBBS, MD, DM (Neurology), DNB (Neurology), Fellowship in Epilepsy, MNAMS, FRCP (Glasg) (UK), MRCP (UK) (Neurology)) is a Group Coordinator & Senior Consultant Neurologist at KIMSHEALTH, Trivandrum. He has over 17 years of experience in the field of Neurology. Dr Syamlal specialises in treating Stroke, Epilepsy, Movement Disorder, Multiple Sclerosis, Dementia, Headache, Peripheral neuropathy, Critical care Neurology, Neuropsychology.
